Sign In
Buy CNCE
$8.37
+0 (+0%)
At Close: May 30, 2023
Are These Trending Penny Stocks Worth Buying at Current Levels?
04:01pm, Friday, 05'th Nov 2021
Check these trending penny stocks out for your watchlist The post Are These Trending Penny Stocks Worth Buying at Current Levels? appeared first on Penny Stocks to Buy, Picks, News and Information | P
Concert Pharmaceuticals (CNCE) Stock: Why The Price Surged Today
08:40pm, Thursday, 04'th Nov 2021
The stock price of Concert Pharmaceuticals Inc (NASDAQ: CNCE) increased 27.43% today. This is why it happened.
Why These Penny Stocks Popped Today, 3 to Watch
01:25pm, Thursday, 04'th Nov 2021
Are these penny stocks on your November watchlist? The post Why These Penny Stocks Popped Today, 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Earnings Preview: Concert Pharmaceuticals (CNCE) Q3 Earnings Expected to Decline
04:49pm, Thursday, 28'th Oct 2021
Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
07:00am, Friday, 03'rd Sep 2021
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #AlopeciaAreata--In September, Concert will present virtually at the HC Wainwright and Cantor healthcare conferences.
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2021 Results - Earnings Call Transcript
07:22am, Sunday, 08'th Aug 2021
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2021 Results - Earnings Call Transcript
Analysts Estimate Concert Pharmaceuticals (CNCE) to Report a Decline in Earnings: What to Look Out for
04:47pm, Thursday, 29'th Jul 2021
Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #AlopeciaAreata--Concert will provide an update on the CTP-543 open label, long-term extension study at the 2nd JAK Inhibitors Drug Development Summit.
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q1 2021 Results - Earnings Call Transcript
02:43pm, Tuesday, 04'th May 2021
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q1 2021 Results - Earnings Call Transcript
Concert Pharmaceuticals Reports First Quarter 2021 Financial Results
07:00am, Tuesday, 04'th May 2021
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert reports financial results for the first quarter of 2021.
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
07:00am, Tuesday, 02'nd Mar 2021
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert will present a corporate overview at the H.C. Wainwright and Oppenheimer virtual conferences in March.
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q4 2020 Results - Earnings Call Transcript
12:25am, Sunday, 28'th Feb 2021
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q4 2020 Results - Earnings Call Transcript
Concert Pharmaceuticals Reports 2020 Financial Results and Provides Update on Clinical Programs
07:00am, Thursday, 25'th Feb 2021
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert reports financial results for the year ended December 31, 2020.
Concert Pharmaceuticals to Report Full Year 2020 Results on February 25, 2021
07:00am, Thursday, 18'th Feb 2021
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--The Company will host a conference call and webcast on February 25, 2021, to discuss 2020 financial results and provide a business update.
Why Concert Pharmaceuticals Stock Cratered Today
03:47pm, Monday, 01'st Feb 2021
The company's experimental schizophrenia drug flopped in a phase 2 study.
